Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 98,459,627
- Total 13F shares
- 68,068,127
- Share change
- +148,230
- Total reported value
- $3,153,029,340
- Put/Call ratio
- 80%
- Price per share
- $46.33
- Number of holders
- 225
- Value change
- +$13,205,113
- Number of buys
- 139
- Number of sells
- 94
Report period
Q4 2022
Institutions
225
Top holders
10
RARE full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.3%
|
6,161,866
|
$255,163,000 | — | 30 Sep 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.1%
|
6,046,038
|
$250,367,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.8%
|
4,756,956
|
$196,987,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
3,927,629
|
$162,645,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.9%
|
3,816,397
|
$158,037,000 | — | 30 Sep 2022 | |
| Capital International Investors |
13F
|
Company |
3.4%
|
3,391,082
|
$140,425,000 | — | 30 Sep 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.8%
|
2,762,822
|
$114,408,000 | — | 30 Sep 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.6%
|
2,607,431
|
$107,974,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,559,544
|
$105,991,000 | — | 30 Sep 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.4%
|
2,359,996
|
$97,727,000 | — | 30 Sep 2022 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
2,211,959
|
$91,597,000 | — | 30 Sep 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
2.1%
|
2,051,600
|
$84,957,000 | — | 30 Sep 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
1,313,533
|
$54,393,000 | — | 30 Sep 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.2%
|
1,187,992
|
$49,195,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.1%
|
1,119,395
|
$46,384,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,011,188
|
$41,874,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
1%
|
979,779
|
$40,572,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
924,877
|
$38,299,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
829,667
|
$34,357,000 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.78%
|
765,120
|
$31,683,619 | — | 30 Sep 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.76%
|
750,000
|
$31,058,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.75%
|
735,710
|
$30,465,000 | — | 30 Sep 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.7%
|
684,344
|
$28,339,000 | — | 30 Sep 2022 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.64%
|
627,203
|
$25,972,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.48%
|
472,354
|
$19,560,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.48%
|
470,974
|
$19,503,000 | — | 30 Sep 2022 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.46%
|
453,794
|
$18,792,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.41%
|
400,106
|
$16,568,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
367,188
|
$15,205,000 | — | 30 Sep 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
365,713
|
$15,145,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
365,106
|
$15,120,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.36%
|
350,687
|
$14,522,000 | — | 30 Sep 2022 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.35%
|
347,081
|
$14,373,000 | — | 30 Sep 2022 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.35%
|
340,000
|
$14,079,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
336,996
|
$13,955,000 | — | 30 Sep 2022 | |
| AXA S.A. |
13F
|
Company |
0.33%
|
322,399
|
$13,350,543 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.32%
|
312,771
|
$12,952,000 | — | 30 Sep 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
305,800
|
$12,663,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.3%
|
295,402
|
$12,233,000 | — | 30 Sep 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
262,364
|
$10,639,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.26%
|
255,389
|
$10,576,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.25%
|
244,579
|
$10,128,000 | — | 30 Sep 2022 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.24%
|
238,204
|
$9,864,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.22%
|
220,880
|
$9,147,000 | — | 30 Sep 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.22%
|
217,075
|
$8,989,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.22%
|
213,650
|
$8,846,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
204,157
|
$8,454,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.19%
|
189,094
|
$7,830,000 | — | 30 Sep 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.19%
|
188,421
|
$7,803,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
183,006
|
$7,579,000 | — | 30 Sep 2022 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q4 2022
As of 31 Dec 2022,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,068,127 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, FEDERATED HERMES, INC., Avidity Partners Management LP, STATE STREET CORP, Clearbridge Investments, LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
226
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
223
Q4 2022 holders
225
Holder diff
2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.